Relationship between major and minor salivary gland mucoepidermoid carcinoma malignancy grading and presence of stromal myofibroblasts: Immunohistochemical study

Journal of Oral Pathology and Medicine

Volumn 33, Issue 6, 2004, Pages 335-339

  Veras Sobral, Ana Paula ^a   Loducca, Silvia Vanessa L ^b   Daumas Nunes, Fábio ^b   Soares De Araújo, Ney ^b   Kowalski, Luiz Paulo ^c   Cavalcanti De Araújo, Vera ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Desmoplasia; Immunohistochemistry; Mucoepidermoid carcinoma; Myofibroblast; Transforming growth factor

Indexed keywords

ALPHA ACTIN; DESMIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; METASTASIS; MINOR SALIVA GLAND; MYOFIBROBLAST; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; STROMA; TISSUE SECTION;

EID: 3142777054     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00111.x     Document Type: Article

References (34)

1. Ellis GL, Auclauir PL. Atlas of Tumor Pathology: Tumors of the Salivary Gland. 3rd ed. Washington. DC: AFIP, 1995; 468.
2. Loyola AM, Araújo VC, Sousa SOM, Araújo NS. Minor salivary gland tumours. A retrospective study of 164 cases in a brazilian population. Oral Oncol Eur J Cancer 1995; 31B: 197-201.
3. Lopes MA, Santos GC, Kowalski. LP. Multivariate analysis of 128 cases of oral cavity minor salivary gland carcinoma. Head Neck 1998; 20: 699-706.
4. Lopes MA, Santos GC, Kowalski LP, Almeida OP. A clinicopathology study of 196 intraoral minor salivary gland tumours. J Oral Pathol Med 1999; 28: 264-7.
5. Jones AS, Beasley NJP, Houghton DJ, Helliwell TR, Husband DJ. Tumours of the minor salivary glands. Clin Otoryngol 1998; 23: 27-33.
6. Cotran RS, Kumar V, Collins T. Neoplasia. In: Pathologic Basis of Disease, Philadelphia, PA: Saunders, 1999; 1425.
7. Rønnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts: implications for myofibroblast generation in breast neoplasia. Lab Invest 1993; 68: 696-707.
8. Desmoulière A, Geinoz A, Gabiani F, Gabiani G. Tranforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-11.
9. Auclair PL, Goode RK, Ellis. GL. Mucoepidermoid carcinoma of intraoral salivary glands: evaluation and application of grading criteria in 143 cases. Cancer 1992; 69: 2021-30.
10. Goode RK, Auclair PL, Ellis. GL. Mucoepidermoid carcinoma of major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998; 82: 1217-24.
11. Evans HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984; 8: 696-701.
12. Araújo VC, Sousa SOM, Carvalho YR, Araújo NS. Application of immunohistochemical to the diagnosis of salivary gland tumors. Appl Imunohistochem Mol Morph 2000; 8: 195-202.
13. Eversole LR, Rovin S, Sabes WR. Mucoepidermoid carcinoma of minor salivary glands: reported of 17 cases with follow-up. J Oral Sur 1972; 30: 107-12.
14. Seifter G, Brocheriou C, Cardesa A, Eveson JW. WHO International histological classification of tumors. Tentative histological classification of salivary gland tumours. Pathol Res Pratic 1990; 186: 555-81.
15. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblast cells: expression of cytoskeletal proteins as marker of phenotypic modulation. Lab Invest 1990; 63: 144-61.
16. Buoro S, Ferrarese P, Chavegato A, et al. Myofibroblast-derived smooth muscle cells during remodeling of rabbit urinary bladder wall induced by partial outflow obstruction. Lab Invest 1993; 69: 589-602.
17. Chiavegato A, Bochaton-Piallat ML, D'Amore E, Sartore S, Gabbiani G. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myfibroblasts form from different fibrotic settings during neoplasm. Virchows Arch 1995; 426: 77-86.
18. Schürch W, Seemayer TA, Gabbiani G. Myofibroblast. In: Sternberg SS, ed. Histology for Pathologists. Philadelphia: Lippincott-Raven Publishers, 1997; 129-65.
19. Roche WR. Myofibroblasts. J Pathol 1990; 161: 281-2.
20. Vasuedo KS, Harris MA. Sarcoma of myofibroblasts: an ultrastructural study. Arch Pathol Lab Med 1978; 102: 185-8.
21. Schürch W, Seemayer TA, Lagacé R, Gabbiani F. The intermediate filament cytoskeleton of myofibroblast: an immunofluorescence and ultrastructural study. Virchows Arch 1984; 403: 323-36.
22. Schürch W, Seemayer TA, Gabbiani F. The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 1998; 22: 141-7.
23. Dotte GP. Signal transduction pathways controlling the switch between keratinocyte growth and differentiation. Crit Rev Oral Biol Medical 1999; 10: 442-57.
24. Prime SS, Matthews JB, Patel V, et al. TGFβ receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellulr differentiation in human oral keratinocytes. Int J Cancer 1994; 56: 406-12.
25. Maiorano E, Ciampolillo A, Gesualdo L, Ranieri E, Fanelli M, Viale G. Expression of transforming growth factor-β1 in thyroid tumors. Appl Imunohistochem Mol Morph 1999; 7: 135-41.
26. Massagué J. The transforming growth factor- β family. Annu Rev Cell Biol 1990; 6: 597-641.
27. Desmoulière A, Rubbia-Brandt L, Abdiu A, Walz T, Marcieira-Coelho A, Gabiani G. α-Smooth muscle actin is expressed in a subpopulation of cultured and clone fibroblasts and id modulated by γ-interferon. Exper Cell Res 1992; 210: 64-73.
28. Walker RA, Dearing SJ, Gallacher B. Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1974; 69: 1160-5.
29. Grosch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistichemical staining for transforming growth factorβ associates with disease progression in human breast cancer. Cancer Res 1992; 52: 6949-52.
30. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002; 82: 85-91.
31. Davies M, Prime SS, Stone AM, Huntley SP, Eveson JW, Paterson IC. Endogenous TGFβ1 inhibits the growth and metastatic dissemination of rat bucal carcinoma cell lines but enhances local bone resorption. J Oral Pathol Med 2000; 29: 232-40.
32. Azuma M, Yuki T, Tamatani T, Motegi K, Yoshida H, Sato M. Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones. Int J Cancer 1996; 66: 802-5.
33. Donnelly MJ, Patel V, Yeudall Game SM, Scully C, Prime SS. Autocrine production of TGFα and TGFβ during tumor progression of rat oral keratinocytes. Carcinogenises 1993; 1: 981-5.
34. Plichowska M, Kimura N, Fujiwara H, Nagura H. Imunnohistochemical sudy of TGFα and TGFβ1, EGFR and IGF-1 expression in human breast carcinoma. Mod Pathol 1997; 10: 969-75.